Mechanisms of varicose vein formation: Valve dysfunction and wall dilation

Phlebology

Volumn 23, Issue 2, 2008, Pages 85-89

  Raffetto, Joseph D ^a   Khalil, R A ^b,c  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chronic venous disease; Inflammation; Matrix metalloproteinases; Varicose veins; Venous pressure

Indexed keywords

MATRIX METALLOPROTEINASE; SCLEROPROTEIN;

APOPTOSIS; CELL ACTIVATION; CELL DAMAGE; CELL INFILTRATION; CHRONIC VEIN INSUFFICIENCY; DISEASE PREDISPOSITION; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; FIBROSIS; HUMAN; INFLAMMATION; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; VALVULAR HEART DISEASE; VARICOSIS; VEIN DILATATION; VEIN TONE; VEIN WALL; VENOCONSTRICTION; VENOUS PRESSURE; ANIMAL; LESIONS AND DEFECTS; METABOLISM; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VEIN INSUFFICIENCY;

ANIMALS; APOPTOSIS; DILATATION, PATHOLOGIC; ENDOTHELIUM, VASCULAR; HUMANS; MATRIX METALLOPROTEINASES; MUSCLE, SMOOTH, VASCULAR; VARICOSE VEINS; VENOUS INSUFFICIENCY; VENOUS PRESSURE;

EID: 44949120819     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2007.007027     Document Type: Review

References (81)

1. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248-1252
2. 2 Bergan JJ, Schmid-Schonbein GW, Coleridge-Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med 2006;355:488-498 (Pubitemid 44162276)
3. Pollack AA, Wood EH. Venous pressure in the saphenous vein at the ankle in man during exercise and changes in posture. J Appl Physiol 1949;1:649-662
4. 4 Recek C. Conception of the venous hemodynamics in the lower extremity. Angiology 2006;57:556-563 (Pubitemid 44566366)
5. Zhou D, Lee HS, Villarreal F, et al. Differential MMP-2 activity of ligament cells under mechanical stretch injury: an in vitro study on human ACL and MCL fibroblasts. J Orthop Res 2005;23:949-957
6. 6 Asanuma K, Magid R, Johnson C, Nerem RM, Gslis ZS. Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2003;284:H1778-84 (Pubitemid 36460794)
7. 7 Milkiewicz M, Haas TL. Effect of mechanical stretch on HIF-1falphag and MMP-2 expression in capillaries isolated from overloaded skeletal muscles: laser capture microdissection study. Am J Physiol Heart Circ Physiol 2005;289:H1315-20 (Pubitemid 41208978)
8. 8 Schmid-Shonbein GW, Takase S, Bergan JJ. New advances in the understanding of the pathophysiology of chronic venous insufficiency. Angiology 2001;52 (suppl. 1):S27-34 (Pubitemid 32777513)
9. 9 Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827-839 (Pubitemid 36542523)
10. 10 Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-262 (Pubitemid 34633925)
11. 11 Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75:346-359 (Pubitemid 350298459)
12. 12 Bergan JJ, Schmid-Shonbein GW, Coleridge-Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med 2006;355:488-498 (Pubitemid 44162276)
13. 13 Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham Study. Am J Prev Med 1988;4:96-101 (Pubitemid 18166355)
14. 14 Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkes FG. What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. Br Med J 1999;318:353-356 (Pubitemid 29192081)
15. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Commun Health 1999;53:149-153
16. Ruckley CV, Evans CJ, Allan PL, Lee AJ, Fowkes FG. Chronic venous insufficiency: clinical and duplex correlations. The Edinburgh Vein Study of venous disorders in the general population. J Vasc Surg 2002;36:520-525
17. Scott TE, LaMorte WW, Gorin DR, Menzoian JO. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg 1995;22:622-628
18. 18 Jawien A. The influence of environmental factors in chronic venous insufficiency. Angiology 2003;54 (suppl. 1): S19-31 (Pubitemid 36935348)
19. Lee AJ, Evans CJ, Allan PL, Ruckley CV, Fowkes FG. Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study. J Clin Epidemiol 2003;56:171-179
20. 20 Lacroix P, Aboyans V, Preux PM, Houles MB, Laskar M. Epidemiology of venous insufficiency in an occupational population. Int Angiol 2003;27:172-176 (Pubitemid 36869387)
21. 21 Christopoulos D, Nicolaides AN, Szendro G. Venous reflux: quantification and correlation with the clinical severity of chronic venous disease. Br J Surg 1988;75:352-356 (Pubitemid 18134955)
22. Zamboni P, Scapoli GL, Lanzara V, et al. Serum iron and matrix metalloproteinase-9 in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg 2005;31:644-649
23. Zamboni P, Izzo M, Tognazzo S, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med 2006;40:1869-1873
24. Zamboni P, De Mattei M, Ongaro A, et al. Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells. Vasc Endovasc Surg 2004;38:431-438
25. Zamboni P, Tognazzo S, Izzo M, et al. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg 2005;42:309-314
26. Tognazzo S, Gemmati D, Pallazzo A, et al. Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers. J Vasc Surg 2006;44:815-819
27. Gemmati D, Tognazzo S, Catozzi L, et al. Influence of gene polymorphisms in ulcer healing process after superficial venous surgery. J Vasc Surg 2006;44:554-562
28. Noel AA, Gloviczki P, Cherry KJ, Rooke TW, Stanson AW, Driscoll DJ. Surgical treatment of venous malformations in Klippel-Trenaunay syndrome. J Vasc Surg 2000;32:840-847
29. 29 Delis KT, Gloviczki P, Wennberg PW, Rooke TW, Driscoll DJ. Hemodynamic impairment, venous segmental disease, and clinical severity scoring in limbs with Klippel-Trenaunay syndrome. J Vasc Surg 2007;45:561-567 (Pubitemid 46281522)
30. Brice G, Mansour S, Bell R, et al. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 2002;39:478-483
31. 31 Ng MY, Andrew T, Spector TD, Jeffery S. Lymphoedema Consortium. Linkage to the FOXC2 region of chromosome 16 for varicose veins in otherwise healthy, unselected sibling pairs. J Med Genet 2005;42:235-239 (Pubitemid 40380304)
32. Saiki S, Sakai K, Saiki M, et al. Varicose veins associated with CADASIL result from a novel mutation in the Notch3 gene. Neurology 2006;67:337-339
33. Lee S, Lee W, Choe Y, et al. Gene expression profiles in varicose veins using complementary DNA microarray. Dermatol Surg 2005;31:391-395
34. 34 Dalal A, Phadke SR. Hemihyperplasia with Ehlers- Danlos syndrome like skin changes. Clin Dysmorphol 2005;14:207-208 (Pubitemid 41400278)
35. Badauy CM, Gomes SS, Sant'ana Filho M, Chies JA. Ehlers-Danlos Syndrome (EDS) type IV. Review of the literature. Clin Oral Invest 2007;11:183-187
36. 36 McKusick VA. The defect in Marfan syndrome. Nature 1991;352:279-281 (Pubitemid 21912334)
37. Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 2002;106:479-483
38. 38 Sansilvestri-Morel P, Rupin A, Badier-Commander C, Fabiani JN, Verbeuren TJ. Chronic venous insufficiency: dysregulation of collagen synthesis. Angiology 2003;54 (suppl. 1):S3-8 (Pubitemid 36935347)
39. Labropoulos N, Tiongson J, Pryor L, et al. Definition of venous reflux in lower extremity veins. J Vasc Surg 2003;38:793-798
40. Labropoulos N, Giannoukas AD, Delis K, et al. Where does venous reflux start? J Vasc Surg 1997;26:736-742
41. 41 Labropoulos N, Kang SS, Mansour MA, Giannoukas AD, Buckman J, Baker WH. Primary superficial vein reflux with competent saphenous trunk. Eur J Vasc Endovasc Surg 1999;18:201-206 (Pubitemid 29431343)
42. Labropoulos N, Leon L, Kwon S, et al. Study of venous reflux progression. J Vasc Surg 2005;41:291-295
43. Caggiati A, Rosi C, Heyen R, Franceschini M, Acconcia MC. Age-related variations of varicose veins anatomy. J Vasc Surg 2006;44:1291-1295
44. 44 Gandhi RH, Irizarry E, Neckman GB, Halpern VJ, Mulcare RJ, Tilson MD. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993;20:814-820 (Pubitemid 23346905)
45. Parra JR, Cambria RA, Hower CD, et al. Tissue inhibitor of metalloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the leg. J Vasc Surg 1998;28:669-675
46. Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol 2000;192:105-112
47. Kirsch D, Wahl W, Bottger T, Junginger T. Primary varicose veins - changes in the venous wall and elastic behavior. Chirurg 2000;71:300-305
48. Kirsch D, Dienes HP, Kuchle R, et al. Changes in the extracellular matrix of the vein wall - the cause of primary varicosis? Vasa 2000;29:173-177
49. 49 Thomas PR, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J 1988;296:1693-1695 (Pubitemid 18151660)
50. 50 Saharay M, Shields DA, Porter JB, Scurr JH, Coleridge- Smith PD. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 1997;26:265-273 (Pubitemid 27362663)
51. 51 Takase S, Schmid-Shonbein GW, Bergan JJ. Leukocyte activation in patients with venous insufficiency. J Vasc Surg 1999;30:148-156 (Pubitemid 29340630)
52. Powell CC, Rohrer MJ, Barnard MR, Peyton BD, Furman MI, Michelson AD. Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg 1999;30:844-851
53. Takase S, Bergan JJ, Schmid-Shonbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 2000;14:427-435
54. Delis KT, Husmann M, Kalodiki E, Wolfe JH, Nicolaides AN. In situ hemodynamics or perforating veins in chronic venous insufficiency. J Vasc Surg 2001;33:773-782
55. Vanscheidt W, Rabe E, Naser-Hijazi B, et al. The efficacy and safety of coumarin-troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomized study. Vasa 2002;31:185-190
56. Siebert U, Brach M, Sroczynski G, Berla K. Efficacy, routine effectiveness, and safety of horse chestnut seed extract in the treatment of chronic venous insufficiency. A meta-analysis of randomized controlled trials and large observational studies. Int Angiol 2002;21:305-315
57. 57 Takase S, Pascarella L, Lerond L, Bergan JJ, Schmid- Shonbein GW. Venous hypertension, inflammation and valve remodeling. Eur J Vasc Endovasc Surg 2004;28:484-493 (Pubitemid 39307440)
58. Jacob MP, Cazaubon M, Scemama A, et al. Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins. Circulation 2002;106:535-538
59. Gillespie DL, Patel A, Fileta B, et al. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13. J Surg Res 2002;106:233-238
60. Woodside KJ, Hu M, Burke A, et al. Morphologic characteristics of varicose veins: possible role of metalloproteinases. J Vasc Surg 2003;38:162-169
61. 61 Kosugi I, Urayama H, Kasashima F, Ohtake H, Watanabe Y. Matrix metalloproteinase-9 and urokinase-type plasminogen activator in varicose veins. Ann Vasc Surg 2003;17:234-238 (Pubitemid 36687570)
62. 62 Kowalewski R, Sobolewski K, Wolanska M, Gacko M. Matrix metalloproteinases in the vein wall. Int Angiol 2004;23:164-169 (Pubitemid 39419779)
63. 63 Takase S, Pascarella L, Bergan JJ, Schmid-Schonbein GW. Hypertension-induced venous valve remodeling. J Vasc Surg 2004;39:1329-1334 (Pubitemid 38952604)
64. 64 Pascarella L, Schmid-Schonbein GW, Bergan JJ. An animal model of venous hypertension: the role of inflammation in venous valve failure. J Vasc Surg 2005;41:303-311 (Pubitemid 40342483)
65. 65 Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-1312 (Pubitemid 28406816)
66. 66 Ascher E, Jacob T,Hingorani A, Gunduz Y, Mazzariol F, Kallakuri S. Programmed cell death (apoptosis) and its role in the pathogenesis of lower extremity varicose veins. Ann Vasc Surg 2000;14:24-30 (Pubitemid 30075463)
67. Ducasse E, Giannakakis K, Chevalier J, et al. Dysregulated apoptosis in primary varicose veins. Eur J Vasc Endovasc Surg 2005;29:316-323
68. Sansilvestri-Morel P, Nonotte I, Fournet-Bourguignon MP, et al. Abnormal deposition of extracellular matrix proteins by cultured smooth muscle cells from human varicose veins. J Vasc Res 1998;35:115-123
69. 69 Sansilvestri-Morel, Rupin A, Jullien ND, et al. Decreased production of collagen type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3. J Vasc Res 2005;42:388-398 (Pubitemid 41368957)
70. Sansilvestri-Morel, Fioretti F, Rupin A, et al. Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes? Clin Sci (Lond) 2007;112:229-239
71. 71 Pascarella L, Penn A, Schmid-Schonbein GW. Venous hypertension and the inflammatory cascade: major manifestations and trigger mechanisms. Angiology 2005;56 (suppl. 1):S3-10 (Pubitemid 41376942)
72. Herouy Y, Nockowski P, Schopf E, Norgauer J. Lipodermatosclerosis and the significance of proteolytic remodeling in the pathogenesis of venous ulceration. Int J Mol Med 1999;3:511-515
73. 73 Thulesius O. The venous wall and valvular function in chronic venous insufficiency. Int Angiol 1996;15:114-118 (Pubitemid 26182239)
74. + channels. Relevance to varicose vein formation. J Vasc Surg 2007;45:373-380
75. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 2006;26:1215-1225
76. 76 Cai WJ, Kocsis E, Luo X, Schaper W, Schaper J. Expression of endothelial nitric oxide synthase in the vascular wall during arteriogenesis. Mol Cell Biochem 2004;264:193-200 (Pubitemid 39366117)
77. 77 Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clin Exp Pharmacol Physiol 2004;31:641-649 (Pubitemid 39329768)
78. 78 Coleman HA, Tare M, Parkington HC. K+ currents underlying the action of endothelium-derived hyperpolarizing factor in guinea pig, rat and human blood vessels. J Physiol 2001;531:359-373 (Pubitemid 32229662)
79. Cohen RA. The endothelium-derived hyperpolarizing factor puzzle. A mechanism without a mediator? Circulation 2005;111:724-727
80. 2+ entry mechanisms of vascular contraction. J Vasc Surg 2004;40:1001-1010
81. Dawber TR, Kannel WB. The Framingham study. An epidemiological approach to coronary heart disease. Circulation 1966;34:553-555